{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:12:12Z","timestamp":1769148732061,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.drugalcdep.2012.12.026","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T14:45:35Z","timestamp":1358433935000},"page":"47-52","source":"Crossref","is-referenced-by-count":14,"title":["Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness"],"prefix":"10.1016","volume":"132","author":[{"given":"Shadi","family":"Nahvi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimber P.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia H.","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ntr\/ntq215","article-title":"Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey","volume":"13","author":"Balmford","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0010","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1185\/03007990903526461","article-title":"Evaluation of varenicline as an aid to smoking cessation in UK general practice \u2013 a THIN database study","volume":"26","author":"Blak","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0015","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2146\/ajhp100196","article-title":"Mental health stability in veterans with posttraumatic stress disorder receiving varenicline","volume":"67","author":"Campbell","year":"2010","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ntr\/ntr003","article-title":"Adherence to varenicline in the COMPASS Smoking Cessation Intervention Trial","volume":"13","author":"Catz","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0025","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1136\/tc.6.suppl_2.S63","article-title":"Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992\u20131993","volume":"6","author":"Cummings","year":"1997","journal-title":"Tob. Control"},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0030","unstructured":"Fiore, M.C., Ja\u00e9n, C.R., Baker, T.B., Bailey, W.C., Benowitz, N.L., Curry, S.J., Dorfman, S.F., Froelicher, E.S., Goldstein, M.G., Healton, C.G., Henderson, P.N., Heyman, R.B., Koh, H.K., Kottke, T.E., Lando, H.A., Mecklenburg, R.E., Mermelstein, R.J., Mullen, P.D., Orleans, C.T., Robinson, L., Stitzer, M.L., Tommasello, A.C., Villejo, L., Wewers, M.E., 2008. Treating Tobacco Use and Dependence. Clinical Practice Guideline. http:\/\/www.ahrq.gov\/clinic\/tobacco\/treating_tobacco_use08.pdf (accessed 10.09.12)."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jsat.2007.02.006","article-title":"Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States","volume":"34","author":"Friedmann","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0740-5472(02)00280-5","article-title":"Optimizing smoking cessation outcomes among the methadone maintained","volume":"23","author":"Frosch","year":"2002","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jsat.2006.06.011","article-title":"Attitudes toward the integration of smoking cessation treatment into drug abuse clinics","volume":"32","author":"Fuller","year":"2007","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jsat.2008.09.001","article-title":"Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting","volume":"36","author":"Halperin","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ntr\/ntq047","article-title":"Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence","volume":"12","author":"Hays","year":"2010","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/pmed.1994.1009","article-title":"Tobacco use as a distal predictor of mortality among long-term narcotics addicts","volume":"23","author":"Hser","year":"1994","journal-title":"Prev. Med."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jsat.2011.06.007","article-title":"How is tobacco treatment provided during drug treatment?","volume":"42","author":"Hunt","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0075","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.1996.03530380039029","article-title":"Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort","volume":"275","author":"Hurt","year":"1996","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0080","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/pmed.2000.0670","article-title":"The use of nicotine patches with minimal intervention","volume":"30","author":"Jolicoeur","year":"2000","journal-title":"Prev. Med."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0090","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00213-004-1971-y","article-title":"Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation","volume":"177","author":"Lam","year":"2005","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0095","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","article-title":"Smoking and mental illness: a population-based prevalence study","volume":"284","author":"Lasser","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11606-009-0926-8","article-title":"Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline","volume":"24","author":"McClure","year":"2009","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/10550490802138814","article-title":"Preliminary study of buprenorphine and bupropion for opioid-dependent smokers","volume":"17","author":"Mooney","year":"2008","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0110","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.addbeh.2006.01.006","article-title":"Cigarette smoking and interest in quitting in methadone maintenance patients","volume":"31","author":"Nahvi","year":"2006","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15504263.2012.663675","article-title":"Varenicline for smoking cessation in schizophrenia: safety and effectiveness in a 12-week open-label trial","volume":"8","author":"Pachas","year":"2012","journal-title":"J. Dual Diagn."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1345\/aph.1G324","article-title":"Outcomes of bupropion therapy for smoking cessation during routine clinical use","volume":"40","author":"Paluck","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0125","doi-asserted-by":"crossref","first-page":"e2856","DOI":"10.1136\/bmj.e2856","article-title":"Risk of cardiovascular serious adverse eventsassociated with varenicline use for tobacco cessation: systematic review and meta-analysis","volume":"344","author":"Prochaska","year":"2012","journal-title":"Br. Med. J."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0130","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1345\/aph.1L661","article-title":"Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness","volume":"43","author":"Purvis","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsat.2007.08.010","article-title":"Smoking cessation treatment in community-based substance abuse rehabilitation programs","volume":"35","author":"Reid","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-597X-1-23","article-title":"A rationale and model for addressing tobacco dependence in substance abuse treatment","volume":"1","author":"Richter","year":"2006","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1300\/J069v24n04_06","article-title":"Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients","volume":"24","author":"Richter","year":"2005","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0150","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1176\/appi.ps.55.11.1258","article-title":"Smoking cessation services in U.S. methadone maintenance facilities","volume":"55","author":"Richter","year":"2004","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0155","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized Trial","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0160","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.clinthera.2008.09.016","article-title":"Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers","volume":"30","author":"Shiffman","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0165","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1046\/j.1360-0443.2002.00221.x","article-title":"Smoking cessation in methadone maintenance","volume":"97","author":"Shoptaw","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0170","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1503\/cmaj.110218","article-title":"Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis","volume":"183","author":"Singh","year":"2011","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0175","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1503\/cmaj.111-2070","article-title":"Varenicline: quantifying the risk","volume":"183","author":"Squire","year":"2011","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0180","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1360-0443.2007.02083.x","article-title":"Varenicline in the routine treatment of tobacco dependence: a pre\u2013post comparison with nicotine replacement therapy and an evaluation in those with mental illness","volume":"103","author":"Stapleton","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0185","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1525-1497.2006.00504.x","article-title":"Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers","volume":"21","author":"Stein","year":"2006","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0190","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14622200701188885","article-title":"Smoking cessation patterns in methadone-maintained smokers","volume":"9","author":"Stein","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0195","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1360-0443.2006.01406.x","article-title":"A smoking cessation intervention for the methadone-maintained","volume":"101","author":"Stein","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0200","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1503\/cmaj.111-2063","article-title":"Varenicline: quantifying the risk","volume":"183","author":"Takagi","year":"2011","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0205","unstructured":"U.S. Food and Drug Administration, Information for Healthcare Professionals: Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics). http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm169986.htm (accessed 10.09.12)."},{"key":"10.1016\/j.drugalcdep.2012.12.026_bib0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1207\/s15327558ijbm1301_10","article-title":"Adherence to nicotine replacement patch therapy in cardiovascular patients","volume":"13","author":"Wiggers","year":"2006","journal-title":"Int. J. Behav. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612005029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612005029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T12:34:15Z","timestamp":1539952455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612005029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0376871612005029"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.12.026","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}